ACOG says no to hormone therapy for heart disease prevention

05/24/2013 | PhysiciansBriefing.com

The American College of Obstetricians and Gynecologists issued a committee opinion advising against the use of menopausal hormone therapy for primary or secondary prevention of coronary heart disease. The group said there is not enough evidence linking long-term estrogen treatment or hormone therapy to improved cardiovascular outcomes. "As with younger women, use of hormone therapy and estrogen therapy should be individualized based on each woman's risk-benefit ratio and clinical presentation," ACOG said in the journal Obstetrics & Gynecology.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY